Document 0292 DOCN M9590292 TI Human immunodeficiency virus-1 induces increased activity of cellular topoisomerases. DT 9509 AU Jardine D; Tachedjian G; Locarnini S; Birch C; Antiviral Laboratory, Victorian Infectious Diseases Reference; Laboratory, Fairfield Hospital. SO Annu Conf Australas Soc HIV Med. 1994 Nov 3-6;6:217 (unnumbered abstract). Unique Identifier : AIDSLINE ASHM6/95291807 AB The presence of HIV supercoiled DNA in cells infected with this virus suggests a role for topoisomerases in the replication cycle of HIV-1. Previously we have demonstrated topoisomerase I activity in sucrose gradient purified HIV-1 virions from several isolates. By comparing the ionic requirements and inhibition by various drugs of the virus-associated enzyme with a mammalian topoisomerase I, we have concluded that the topoisomerase activity associated with the purified virus particles is of cellular origin. In MT-2 cells infected with HIV-1, inhibitors of both eukaryotic topoisomerase I and II failed to exhibit an antiviral effect at non-toxic levels. Topoisomerase I and II were extracted at various times after infection with HIV-1 and placed into in vitro assays designed to detect topoisomerase activity. Quantitation of human topoisomerase I and II activity levels revealed that HIV-1 induces an increase in both topoisomerase I and II activity during infection. The increase in topoisomerase I activity occurs almost immediately post-infection whilst the increase in topoisomerase II occurs late in infection. These increases in intracellular enzymatic activity are not reflected in Western Blot profiles, possibly indicating phosphorylation of the enzymes to an active form. DE Cell Line, Transformed DNA Topoisomerase/*BIOSYNTHESIS DNA Topoisomerase (ATP-Hydrolysing)/*BIOSYNTHESIS Enzyme Induction/PHYSIOLOGY Human HIV-1/*PATHOGENICITY Virus Integration/*PHYSIOLOGY Virus Replication/*PHYSIOLOGY MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).